A peptide-based adjuvant therapy to reduce the toxicity of Amphotericin B (2021–2023)

Grant type:
Gilead Sciences Research Scholars Program in Anti-Fungals
Researchers:
  • Senior Lecturer
    School of Chemistry and Molecular Biosciences
    Faculty of Science
    Affiliate of ARC COE for Innovation
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
Funded by:
Gilead Sciences Inc